Professor of Biomedical Pioneering Innovation Center, Peking-Tsinghua Center for Life Sciences, and School of Life Sciences at Peking University; and the director of Peking University Genome Editing Research Center. The research of Wei group is mainly focused on the development of eukaryotic gene editing tools, with the emphasis on the high-throughput functional genomics and gene therapy. The combination of forward and reverse genetic means are employed, often in a high-throughput fashion, for the understanding of the molecular mechanisms underlying human diseases, including cancer and infection.